HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, announced it has appointed Robert Spitale, Ph.D., Associate Director and Associate Dean of Research in the School of Pharmacy & Pharmaceutical Services at the University of California, Irvine, to the HTG Therapeutics Scientific Advisory Board.
To read the entire HTG press release, click here.